Opella Western Europe, excluding France

Certified B Corporation
Standards version

1.6

Headquarters

Catalonia, Spain

Certified Since

June 2024

Industry

Pharmaceutical products

Sector

Wholesale/Retail

Operates In

Austria,

Belgium,

Germany,

Greece,

Italy,

Portugal,

Spain,

Switzerland,

United Kingdom

Opella Western Europe, excluding France (Opella Healthcare Italy Srl Società Benefit, A.Nattermann & Cie GmbH., Opella Healthcare UK Limited, Opella Healthcare Spain, SL, Opella Healthcare Unipessoal LDA, Opella Healthcare Switzerland AG (ex Pharmaton AG) CH, Opella Healthcare Austria GmbH, Opella Healthcare Belgium NV/SA and Opella Healthcare Greece single Member Ltd) offers a diverse product line of over-the-counter medicines, food supplements and medical devices across several categories, including digestive health, cough and cold, pain and mental health. Our strong portfolio of brands includes Dulcolax, Buscopan and Allegra. Through our consumer-led, science-based products we enable people to champion better self-care and are investing in community well-being, because we believe healthier people and a healthier planet go hand in hand. As guardians of personal health, we are dedicated to growing our business while helping improve the health of people and the planet.

Overall B Impact Score

Based on the B Impact assessment, Opella Western Europe, excluding France earned an overall score of 86.9. The median score for ordinary businesses who complete the assessment is currently 50.9.
86.9
86.9 Overall B Impact Score
80 Qualifies for B Corp Certification
50.9 Median Score for Ordinary Businesses

Governance 12.4


Workers 28.4


Community 16.9


Environment 14.2


Customers 14.7



Additional Documentation

Sanofi Consumer Healthcare Western Europe, excluding France - Transparent Assessment 2024

Sanofi Consumer Healthcare Western Europe, excluding France - Disclosure Report 2024

Sanofi Consumer Healthcare Western Europe, excluding France - Pharmaceutical Industry Disclosure 2024

Sanofi Consumer Healthcare Germany - Disclosure Report 2023

Sanofi Consumer Healthcare Germany - Transparent Assessment 2023

Sanofi Consumer Healthcare Germany - Pharmaceutical Industry Disclosure 2023

Sanofi Consumer Healthcare Italy - Disclosure Report 2023

Sanofi Consumer Healthcare Italy - Transparent Assessment 2023

Sanofi Consumer Healthcare Italy - Pharmaceutical Industry Disclosure 2023

Sanofi CHC WE, excluding France - Score Aggregation Methodology & Brand List (2024)